pcDNA3.1(−)-mediated ribozyme targeting of HER-2 suppresses breast cancer tumor growth

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Biology Reports

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11033-009-9569-4PMID 19444644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of a U16 snoRNA-containing ribozyme library to identify ribozyme targets in HIV-1.

  2008cited by this paper
• Differences in radiosensitivity between three HER2 overexpressing cell lines

  2008cited by this paper
• Reduction in Severity of a Herpes Simplex Virus Type 1 Murine Infection by Treatment with a Ribozyme Targeting the UL20 Gene RNA

  2008cited by this paper
• Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas

  2006cited by this paper
• RNAi in Combination with a Ribozyme and TAR Decoy for Treatment of HIV Infection in Hematopoietic Cell Gene Therapy

  2006cited by this paper
• Oncolytic viral therapies – the clinical experience

  2005cited by this paper
• Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy

  2004cited by this paper
• Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation*

  2004cited by this paper
• Recombinant adenovirus encoding H-ras ribozyme induces apoptosis in laryngeal cancer cells through caspase- and mitochondria-dependent pathways.

  2002cited by this paper
• HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

  2001cited by this paper
• A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

  2001cited by this paper
• Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2 –specific hammerhead ribozyme

  2001cited by this paper
• HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Specific down-regulation of HER-2/neu mediated by a chimeric U6 hammerhead ribozyme results in growth inhibition of human ovarian carcinoma.

  2001influential reference
• The Role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis

  2001cited by this paper
• Ribozymes. Their design and use in cancer.

  2000cited by this paper
• Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma

  2000cited by this paper
• Ribozymes. Their design and use in cancer.

  2000cited by this paper
• Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

  2000influential reference
• Sequence specificity of the hammerhead ribozyme revisited; the NHH rule.

  1998cited by this paper
• HER‐2/neu Signal Transduction in Human Breast and Ovarian Cancer

  1997cited by this paper
• Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.

  1997cited by this paper
• Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.

  1996cited by this paper
• Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.

  1995cited by this paper
• c-erbB-2/neu Oncogene and Ki-67 Analysis in the Assessment of Palatal Salivary Gland Neoplasms

  1995cited by this paper
• Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior.

  1994cited by this paper
• Growth factor signaling by receptor tyrosine kinases.

  1992cited by this paper
• Small catalytic RNAs.

  1992cited by this paper
• Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

  1990cited by this paper
• erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

  1986cited by this paper

• Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy

  2025cites this paper
• Identification of Ascorbic Acid and Gallic Acid as Novel Inhibitors of Secreted Frizzled-Related Protein for the Treatment of Obesity-Induced Type 2 Diabetes

  2022cites this paper
• Correlation of human epidermal growth factor receptor protein expression and colorectal cancer.

  2015cites this paper
• Perspectives on the emerging applications of multifaceted biomedical polymeric nanomaterials

  2015cites this paper
• How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment.

  2012cites this paper
• Potential use of nucleic acid-based agents in the sensitization of nasopharyngeal carcinoma to radiotherapy.

  2012cites this paper
• Clinical implications for BRCA gene mutation in breast cancer

  2012cites this paper
• Network-Scale Engineering: Systems Approaches to Synthetic Biology

  2012cites this paper
• Interactions moléculaires et cellulaires entre les protéines E3-14.7K, FIP-1 et les microtubules : application dans le transfert de gènes

  2012cites this paper
• Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.

  2011cites this paper
• A new approach to an old problem: synthetic biology tools for human disease and metabolism.

  2011cites this paper
• Therapeutic applications of ribozymes and riboswitches.

  2010cites this paper
• Effect of high hydrostatic pressure on hydration and activity of ribozymes

  2010cites this paper